Product image of Medikinet Cr (Methylphenidate Hydrochloride) supplied by GNH India

Medikinet Cr

Active Ingredient:
Methylphenidate Hydrochloride
Origin:
EU

Medikinet Cr (Methylphenidate Hydrochloride)

Methylphenidate hydrochloride, the active ingredient in Medikinet Cr, is a central nervous system stimulant presented as an oral tablet for oral use. It is indicated for the treatment of attention deficit hyperactivity disorder and narcolepsy in patients who require pharmacologic management.

GNH India supplies Medikinet Cr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Medice Arzneimittel Pütter Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Medikinet Cr is a central nervous system stimulant used in the management of neurobehavioral disorders.

  • Attention deficit hyperactivity disorder (children and adolescents): improves focus, reduces hyperactivity and impulsivity.
  • Attention deficit hyperactivity disorder (adults): enhances concentration and supports daily functioning.
  • Narcolepsy: decreases excessive daytime sleepiness and improves wakefulness.

How It Works

  • Methylphenidate hydrochloride inhibits the reuptake of dopamine and norepinephrine by blocking their transporters in the neuronal synapse. This increases the extracellular concentrations of these catecholamines, enhancing neurotransmission in brain regions that regulate attention, impulse control, and wakefulness.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Insomnia: difficulty falling or staying asleep.
  • Decreased appetite: reduced food intake, especially in children.
  • Headache: mild to moderate tension‑type pain.
  • Stomach discomfort: nausea, abdominal pain or dyspepsia.

Serious or Rare Side Effects

  • Cardiovascular events: hypertension, tachycardia, or arrhythmia.
  • Psychiatric symptoms: emergence of psychosis, mania, or severe anxiety.
  • Growth suppression: prolonged use may affect height development in children.

Precautions & Warnings

Before prescribing Medikinet Cr, clinicians should consider several safety aspects.

  • Cardiovascular assessment: evaluate blood pressure and heart rate, especially in patients with pre‑existing heart disease.
  • Psychiatric history: screen for anxiety, bipolar disorder, or psychotic disorders.
  • Growth monitoring: regularly measure height and weight in pediatric patients.
  • Substance misuse: avoid in individuals with a history of drug abuse.
  • Drug interactions: review concomitant medications for potential interactions.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Avoid Interactions

Methylphenidate may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
  • Sympathomimetic agents (e.g., decongestants): may cause severe hypertension or tachycardia.

Moderate Interactions (Monitor Closely):\n- Antidepressants (SSRIs, SNRIs): potential for increased serotonergic activity.

  • Antihypertensives: possible reduction in blood‑pressure‑lowering effect.
  • Antacids: may affect absorption, monitor therapeutic response.

Frequently Asked Questions

Medikinet Cr contains methylphenidate hydrochloride and is prescribed for attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults, as well as for narcolepsy to reduce excessive daytime sleepiness.

Methylphenidate blocks the reuptake of dopamine and norepinephrine, increasing their levels in the brain. This enhances neurotransmission in pathways that control attention, impulse control, and wakefulness, leading to improved focus and reduced sleepiness.

The dose of Medikinet Cr is individualized. A qualified prescriber determines the appropriate strength, frequency and duration based on the patient’s age, clinical response and tolerability.

Safety data are limited. Healthcare providers should weigh potential benefits against risks and consider alternative therapies. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their physician.

To request Medikinet Cr, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Medikinet Cr is a methylphenidate formulation, similar in mechanism to other methylphenidate products but differs in release characteristics. Compared with amphetamine‑based stimulants, it may have a different side‑effect profile and dosing flexibility, allowing clinicians to choose based on patient response and tolerability.

Store Medikinet Cr at ambient temperature, below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Medikinet Cr is taken orally, usually with a glass of water. It may be taken with or without food, as directed by the prescriber, and the tablets should be swallowed whole, not crushed or chewed, unless the product label specifies otherwise.

Serious risks include cardiovascular events such as hypertension or arrhythmia, psychiatric effects like psychosis or mania, and potential for growth suppression in children. Patients should be monitored regularly for these adverse outcomes.

Medikinet Cr is contraindicated in individuals with known hypersensitivity to methylphenidate, those taking monoamine oxidase inhibitors, or patients with severe cardiovascular disorders, uncontrolled hypertension, or a history of psychosis without close supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylphenidate Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT